← FDA DRUG APPROVALS

FDA NDA · NDA019383

PROVENTIL

Sponsor: SCHERING

APPLICATION
NDA019383
TYPE
NDA
ORIGINAL APPROVAL
1987-07-13
LATEST ACTION
2001-04-09
ROUTE
ORAL
DOSAGE FORM
TABLET, EXTENDED RELEASE
MARKETING STATUS
Discontinued

Products

PROVENTILDiscontinued
ALBUTEROL SULFATE EQ 4MG BASE · TABLET, EXTENDED RELEASE · ORAL

Approval history

2001-04-09Manufacturing (CMC) · Supplement 19 · standardAP
1999-05-24Manufacturing (CMC) · Supplement 9 · standardAP
1998-11-06Labeling · Supplement 10 · standardReviewAP
1998-07-15Manufacturing (CMC) · Supplement 13 · standardAP
1997-12-12Manufacturing (CMC) · Supplement 3 · standardAP
1997-09-18Efficacy · Supplement 11 · standardAP
1996-09-09Manufacturing (CMC) · Supplement 8 · standardAP
1993-05-27Manufacturing (CMC) · Supplement 4 · standardAP
1992-06-05Manufacturing (CMC) · Supplement 2 · standardAP
1989-01-24Manufacturing (CMC) · Supplement 1 · standardAP
1987-07-13Type 3 - New Dosage Form · Original · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →